ZA991233B - Use of thiadiazolo pyridine derivatives. - Google Patents

Use of thiadiazolo pyridine derivatives.

Info

Publication number
ZA991233B
ZA991233B ZA9901233A ZA991233A ZA991233B ZA 991233 B ZA991233 B ZA 991233B ZA 9901233 A ZA9901233 A ZA 9901233A ZA 991233 A ZA991233 A ZA 991233A ZA 991233 B ZA991233 B ZA 991233B
Authority
ZA
South Africa
Prior art keywords
thiadiazolo
pyridine derivatives
pyridine
derivatives
thiadiazolo pyridine
Prior art date
Application number
ZA9901233A
Other languages
English (en)
Inventor
Walter-Gunar Friebe
Wolfgang Schaumann
Otto-Henning Wilhelms
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ZA991233B publication Critical patent/ZA991233B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9901233A 1998-02-17 1999-02-16 Use of thiadiazolo pyridine derivatives. ZA991233B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98102675 1998-02-17

Publications (1)

Publication Number Publication Date
ZA991233B true ZA991233B (en) 1999-08-17

Family

ID=8231426

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901233A ZA991233B (en) 1998-02-17 1999-02-16 Use of thiadiazolo pyridine derivatives.

Country Status (10)

Country Link
US (1) US6326378B1 (es)
EP (1) EP1054669B9 (es)
JP (1) JP3585838B2 (es)
AR (1) AR015518A1 (es)
AU (1) AU2926099A (es)
CA (1) CA2318237A1 (es)
DE (2) DE69909592D1 (es)
ES (1) ES2203086T3 (es)
WO (1) WO1999042089A2 (es)
ZA (1) ZA991233B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1193261A1 (en) 2000-10-02 2002-04-03 Warner-Lambert Company New thiadiazoles and their use as phosphodiesterase-7 inhibitors
EP1348433A1 (en) * 2002-03-28 2003-10-01 Warner-Lambert Company LLC Thiazol-2-yl-imine compounds as PDE-7 inhibitors
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
KR20050111759A (ko) * 2003-03-12 2005-11-28 셀진 코포레이션 7-아미노-이소인돌릴 화합물 및 그의 제약학적 용도
US7564337B2 (en) 2005-03-03 2009-07-21 Littelfuse, Inc. Thermally decoupling fuse holder and assembly

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60246389A (ja) * 1984-05-22 1985-12-06 Nippon Soda Co Ltd ２−スルホニルイミノ−２Ｈ−１，２，４−チアジアゾロ〔２，３−ａ〕ピリジン誘導体及びその製造法
DE4131579A1 (de) * 1991-09-23 1993-03-25 Boehringer Mannheim Gmbh Thiadiazolo(4,3-a)pyridinderivate, verfahren zu ihrer herstellung und diese enthaltenden arzneimittel

Also Published As

Publication number Publication date
WO1999042089A2 (en) 1999-08-26
AR015518A1 (es) 2001-05-02
WO1999042089A3 (en) 1999-10-14
DE69909592D1 (de) 2003-08-21
JP3585838B2 (ja) 2004-11-04
DE69909592T4 (de) 2005-03-24
EP1054669B1 (en) 2003-07-16
EP1054669A2 (en) 2000-11-29
CA2318237A1 (en) 1999-08-26
DE69909592T2 (de) 2004-06-03
JP2002503688A (ja) 2002-02-05
US6326378B1 (en) 2001-12-04
AU2926099A (en) 1999-09-06
WO1999042089A9 (en) 1999-10-28
EP1054669B9 (en) 2004-09-15
ES2203086T3 (es) 2004-04-01

Similar Documents

Publication Publication Date Title
HK1036981A1 (en) Imidazo pyridine derivatives which inhibit gastricacid secretion.
CZ20011556A3 (cs) Pyrazolopyridinové deriváty
IL133904A0 (en) Pyridine derivatives
PL346155A1 (en) 1h-imidazopyridine derivatives
HK1032005A1 (en) Polymeric derivatives of camptothecins.
PL345540A1 (en) Thiobenzimidazole derivatives
HU9900120D0 (en) Benzosulfone derivatives
GB9910384D0 (en) Alpha-ketoamide derivatives
ZA9811925B (en) Thiazole derivatives.
AU5065999A (en) Naphthyridine derivatives
PL342060A1 (en) Derivatives of 1,3,4-oxadiaxolone
ZA991550B (en) Cyclohexanediole derivatives.
EG23802A (en) 2-Phenylpyran-4-one derivatives
ATE253569T1 (de) Pde-iv-hemmende pyridin-derivate
ZA991233B (en) Use of thiadiazolo pyridine derivatives.
GB9827729D0 (en) Thieno-indole derivatives
PL347910A1 (en) Ureidopiperidine derivatives as selective human nk3
EP1061912A4 (en) PHENANTHROFURANDERIVATE
ZA9811923B (en) Thiazole derivatives.
IL139276A0 (en) Cyclohexenondioxthio chromanoyl derivatives
GB9706923D0 (en) Pyridine derivatives
HK1042478A1 (zh) 2-氧代-2h-喹啉衍生物
PL341713A1 (en) Derivatives of spiropiperidine
AU1185300A (en) 2-oxoimidazole derivatives
ZA986137B (en) Pyridine derivatives